In Senegal, the pregnant women living with hiv antiretroviral therapy coverage for pmtct currently stands at 72%, reflecting an increase of 6% (9.1%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Senegal
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Senegal
PMTCT antiretroviral therapy coverage
More indicators for Senegal
Male unintentional poisoning
2.6
0.0
(2019)
Female wasting in children
6.7%
-0.8%
(2019)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar79
+intl dollar3
(2021)
Birth registration
78.7%
+1.9%
(2019)
Contraceptive modern method prevalence
25.5%
+0.1%
(2019)
Senegal PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 72% | +6% |
| 2021 | 66% | 0% |
| 2020 | 66% | 0% |
| 2019 | 66% | +4% |
| 2018 | 62% | +9% |
| 2017 | 53% | -3% |
| 2016 | 56% | +3% |
| 2015 | 53% | +12% |
| 2014 | 41% | -6% |
| 2013 | 47% | +15% |
| 2012 | 32% | +6% |
| 2011 | 26% | +4% |
| 2010 | 22% | -5% |
| 2009 | 27% | +11% |
| 2008 | 16% | +6% |
| 2007 | 10% | +4% |
| 2006 | 6% | +5% |
| 2005 | 1% | +1% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |